65,437 trials
Systemic Sclerosis
Primary: Changes From Baseline in Manometric Parameters: i) Amplitude of Contractions at the Distal Part of the Esophagus and ii) Resting and Residual (Lower Esophageal Pressure)…
Allogeneic Stem Cell Transplantation · Refractory Autoimmune Cytopenia(s)
Primary: Number of Participants With Response — 3; 2; 1 participants
Hepatic Failure · Hepatic Impairment · Chronic Hepatitis C Infection With Hepatic Coma
Primary: Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration (AUC0-last) of Buprenorphine, Norbuprenorphine, Naloxone and…
Human Epithelial Receptor (HER)-2 Positive Breast Cancer
Primary: Overall Response Rate — 56; 48 Participants
Depression · Anxiety
Primary: C-Reactive Protein at 12 Weeks — 3.31; 0.50 mg/L — p=.001
Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Cancer
Primary: Postoperative Length of Hospital Stay — 4.4; 4.3 days — p=0.34
Postmenopausal Osteoporosis
Primary: Percentage of Participants With Adherence to Treatment — 98.5; 98.6 percentage of participants
Rheumatoid Arthritis
Primary: Change From Baseline in Disease Activity Score Based on 28-joint Count and Erythrocyte Sedimentation Rate (DAS28-ESR) at Month 6 and Month 12 — 5.53; -1.52; -1.88 units…
Hepatitis B, Chronic
Primary: Number of Hepatitis B Envelope Antigen (HBeAg) Positive Participants With Hepatitis B Virus Deoxyribonucleic Acid (HBV-DNA) Less Than (<) 1,00,000 Copies Per Milliliter…
Recurrent Hypopharyngeal Squamous Cell Carcinoma · Recurrent Laryngeal Squamous Cell Carcinoma · Recurrent Laryngeal Verrucous Carcinoma
Primary: Mean Percent Change in p16 Methylation (% CpG Sites Methylated) in Tumor Tissue After Soy Isoflavone — 4.9 Percent change — p=<0.005
Anxiety Disorders · Mood Disorders · Insomnia
Primary: Insomnia Severity Index — 16.4; 16.5; 14.8; 9.3 units on a scale
Rheumatoid Arthritis
Primary: Percentage of Participants With Categorized Laboratory Data Available at Baseline — 98.6; 49.2; 63.5; 7.3 percentage of participants
Induction of Labor
Primary: Average Time in Hours From Insertion of the Catheter Until Delivery — 19.4; 19.1 HOURS
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Therapy-Related Acute Myeloid Leukemia
Primary: Overall Survival (OS) Time — 9.3; 8.8 months — p=0.30
Non-small Cell Lung Cancer
Primary: Overall Response Rate — 34.63; 33.82 percentage of participans